Literature DB >> 8437850

Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas.

J Young1, B Leggett, M Ward, L Thomas, R Buttenshaw, J Searle, G Chenevix-Trench.   

Abstract

The current model for colorectal tumorigenesis defines four specific mutations (activation of a ras proto-oncogene and inactivation of the APC, p53 and DCC tumor-suppressor genes) that accumulate in a colonic epithelial cell as it progresses towards a carcinoma. However, further mutations must be needed for progression to malignancy because advanced adenomas have been observed with all four of these mutations. Loss of heterozygosity (LOH) for 11 loci spanning the distal portion of the long arm of chromosome 14 was studied in 89 sporadic colorectal adenocarcinomas and 25 adenomas. The overall rate of LOH in carcinomas was 53% (46/86 informative carcinomas). The smallest region of overlap (SRO) of deletions includes the markers D14S19 to D14S20. No LOH was seen in the 18 informative adenomas examined. There was a significant trend towards higher levels of LOH within the SRO in advanced Dukes' stages (P = 0.016). Since frequent loss of heterozygosity in a specific region of a chromosome may reflect the inactivation of a tumor-suppressor gene located there, these data suggest that a gene involved in the progression of colonic neoplasia may reside on the distal portion of the long arm of chromosome 14, and that its inactivation may be a critical event in this process.

Entities:  

Mesh:

Year:  1993        PMID: 8437850

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  Metastatic recurrence of early-stage colorectal cancer is linked to loss of heterozygosity on chromosomes 4 and 14q.

Authors:  F Al-Mulla; S AlFadhli; A H Al-Hakim; J J Going; M S Bitar
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

Review 2.  What we could do now: molecular pathology of colorectal cancer.

Authors:  R S Houlston
Journal:  Mol Pathol       Date:  2001-08

3.  Allelic losses at genomic instability-associated loci in villous adenomas and adjacent colorectal cancers.

Authors:  Bruce M Brenner; Daniel L Stoler; Luz Rodriguez; Matthew J Karpenko; Helen Swede; Nicholas J Petrelli; Garth R Anderson
Journal:  Cancer Genet Cytogenet       Date:  2007-04-01

Review 4.  Genetic prognostic markers in colorectal cancer.

Authors:  R S Houlston; I P Tomlinson
Journal:  Mol Pathol       Date:  1997-12

Review 5.  Current status of human chromosome 14.

Authors:  D Kamnasaran; D W Cox
Journal:  J Med Genet       Date:  2002-02       Impact factor: 6.318

6.  Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis.

Authors:  P Bugert; G Kovacs
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

7.  Hereditary nonpolyposis colon cancer: analysis of linkage to 2p15-16 places the COCA1 locus telomeric to D2S123 and reveals genetic heterogeneity in seven Canadian families.

Authors:  R C Green; S A Narod; J Morasse; T L Young; J Cox; G W Fitzgerald; P Tonin; O Ginsburg; S Miller; S Jothy
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

8.  Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.

Authors:  Meng Chen; Yuanqing Ye; Hushan Yang; Pheroze Tamboli; Surena Matin; Nizar M Tannir; Christopher G Wood; Jian Gu; Xifeng Wu
Journal:  Int J Cancer       Date:  2009-11-15       Impact factor: 7.396

9.  A distinct expression pattern of the long 3'-untranslated region dicer mRNA and its implications for posttranscriptional regulation in colorectal cancer.

Authors:  Yasushi Hamaya; Shigeru Kuriyama; Tetsunari Takai; Ken-Ichi Yoshida; Takanori Yamada; Mitsushige Sugimoto; Satoshi Osawa; Ken Sugimoto; Hiroaki Miyajima; Shigeru Kanaoka
Journal:  Clin Transl Gastroenterol       Date:  2012-07-26       Impact factor: 4.488

10.  Genomic alterations in nasopharyngeal carcinoma: loss of heterozygosity and Epstein-Barr virus infection.

Authors:  A Mutirangura; C Tanunyutthawongese; W Pornthanakasem; V Kerekhanjanarong; V Sriuranpong; S Yenrudi; P Supiyaphun; N Voravud
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.